| 摘要 |
<p>Disclosed in the present invention are a compound and a pharmaceutical composition used for inhibiting the activity of a kidney-type glutaminase, and the use of the compound in treatment, especially in treating or preventing diseases, in particular cancer, related to the increase in activity of glutaminase.</p> |
